CV Sciences, Inc. (CVSI)
| Previous Close | 0.0380 |
| Open | 0.0346 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0316 - 0.0400 |
| 52 Week Range | 0.0300 - 0.0600 |
| Volume | |
| Avg. Volume | 246,293 |
| Market Cap | 6.082M |
| Beta (5Y Monthly) | 0.63 |
| PE Ratio (TTM) | 1.86 |
| EPS (TTM) | 0.0200 |
| Earnings Date | May 13, 2024 - May 17, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Insider MonkeyCV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call Transcript
CV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call Transcript March 28, 2024 CV Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to CV Sciences’ Fourth Quarter and Year-End 2023 Conference. At this time, all participants are […]
PR NewswireCV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the year and quarter ended December 31, 2023.
PR NewswireCV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews
CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, proudly announces its latest innovation and product launch: a premier CBD chew tailored for pets, +PlusCBD™ Pet Hip and Joint Health Chews and +PlusCBD™ Pet Calming Care Chews. +PlusCBD™Pet wellness treats are crafted with the utmost care and supported by extensive research, and
